NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/07/2024
Back to search
Official data from USPTO
PHARMASEQ
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
03/07/2024
Classification
Registered
Trademark type
Combined
Nice classes
42
Filing date
08/06/2001
Registration date
05/11/2004
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/07/2024
Last transaction
03/07/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/01/2001
First use in commerce
10/01/2001
Drawing code
3
Owner type
03
Owner location
Chicago, IL, US
Examiner
SAITO, KIM
Law office
L20
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
P-CHIP IP HOLDINGS INC.
PharmaSeq, Inc.
Representatives
Michael A. Geller DLA Piper LLP (US)
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development of diagnostic assays in vitro and screens for pharmaceutical drug discovery for others; design for others in the field of DNA-based assaysDNA sequencing protocolsimmunoassay and methods for drug discovery; scientific researchdevelopment of methods to tag macroscopic objectsmolecules or groups of molecules with microtranspondersto detect such tagged objects or molecules; biochemical and genetic research for the development of pharmaceuticals or diagnostic methods
Publications
History of USPTO decisions and trademark events.
47 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
03/07/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/07/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/07/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/21/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/21/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/21/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/21/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/21/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
09/21/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/11/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/22/2021
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
06/03/2014
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
06/03/2014
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06/03/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/03/2014
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
05/12/2014
E89R
TEAS SECTION 8 & 9 RECEIVED
05/12/2014
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12/14/2009
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/14/2009
E815
TEAS SECTION 8 & 15 RECEIVED
12/03/2009
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/18/2007
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/18/2007
CORV
REVIEW OF CORRESPONDENCE COMPLETE
05/31/2006
FAXX
FAX RECEIVED
09/10/2004
R.PR
REGISTERED-PRINCIPAL REGISTER
05/11/2004
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/03/2004
DOCK
ASSIGNED TO EXAMINER
02/11/2004
CFIT
CASE FILE IN TICRS
02/10/2004
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/06/2004
EX3G
SOU EXTENSION 3 GRANTED
02/06/2004
IUAF
USE AMENDMENT FILED
01/09/2004
EXT3
SOU EXTENSION 3 FILED
01/09/2004
PAPER RECEIVED
01/09/2004
EX2G
SOU EXTENSION 2 GRANTED
07/29/2003
EXT2
SOU EXTENSION 2 FILED
07/08/2003
PAPER RECEIVED
07/08/2003
EX1G
SOU EXTENSION 1 GRANTED
04/11/2003
PAPER RECEIVED
01/10/2003
EXT1
SOU EXTENSION 1 FILED
01/07/2003
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
07/09/2002
PUBO
PUBLISHED FOR OPPOSITION
04/16/2002
NPUB
NOTICE OF PUBLICATION
03/27/2002
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/23/2001
CNEA
EXAMINER'S AMENDMENT MAILED
10/18/2001
DOCK
ASSIGNED TO EXAMINER
09/28/2001
DOCK
ASSIGNED TO EXAMINER
09/21/2001
Continuous trademark protection
Get notified about every new filing that threatens PHARMASEQ or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.